Magnendo Raises Financing for Development of Magnetic Robotic Navigation System for Neuro-Endovascular Intervention

July 29, 2026—Magnendo Corp. announced the closing of an $18 million Series A financing round led by Penumbra, Inc., with participation from a syndicate of new and existing institutional investors. Magnendo, a spinout of Massachusetts Institute of Technology in Boston, Massachusetts, is developing magnetic robotic navigation technology for neuro-endovascular intervention.

The proceeds from the financing will support the productization of Magnendo’s preclinically validated robotic system and magnetic guidewires and advance the company’s first clinical platform toward first-in-human studies.

Magnendo advised it is developing a robotic system that combines magnetically steerable guidewires with robotic control, advanced medical imaging, and intelligent navigation software to improve endovascular access.

The company stated that the system is designed to help physicians navigate complex vascular anatomy quickly, consistently, and reliably while remaining compatible with existing clinical workflows and commercially available devices.

Preclinical results have shown the potential of the technology to substantially reduce navigation times while improving procedural consistency across operators and anatomies, stated Magnendo.

“Magnendo has developed an elegant and pragmatic approach to one of the most challenging aspects of endovascular intervention,” commented Shruthi Narayan, President of Penumbra, in the Magnendo press release. "We believe the company’s focus on improving navigation while integrating into existing clinical workflows has the potential to meaningfully advance neurovascular care, and we are excited to support the team as they move toward clinical translation.”